This month, Ingress-health team participated in 2 posters being presented at the Transplantation & Cellular Therapy (TCT) Meetings of ASBMT and CIBMTR in Houston, Texas. Based on systematic literature reviews, the research focused on the survival of relapsed/ refractory patients with acute myeloid leukemia (AML) who underwent stem cell transplantation (SCT) after salvage therapy. A second study focused on the burden of hospitalization associated with allo-SCT in AML patients.

The two posters can be retrieved from here and from here.